Mediterranean restaurant chain Cava confidentially files for an IPO

Mediterranean restaurant chain Cava confidentially files for an IPO


A logo outside of a Cava restaurant location in Chantilly, Virginia.

Kristoffer Tripplaar | Sipa USA | AP

Mediterranean chain Cava announced Monday that it has confidentially filed for an initial public offering.

It’s the first restaurant company so far this year to take the first step toward a public market debut, following a drought of IPOs in 2022.

Cava Group was founded in 2006 and opened its first fast-casual location in 2011, modeling its build-your-own Mediterranean meals after the formula made popular by Chipotle Mexican Grill. In 2018, it bought Zoes Kitchen for $300 million, taking the chain private. The company converted Zoes locations into new Cava restaurants, rapidly expanding its footprint.

Cava also sells its dips and spreads, like spicy hummus, tzatziki and tahini dressing, at Whole Foods and other grocery stores.

The company raised $230 million in April 2021 at a valuation of $1.71 billion, according to Pitchbook data.

Cava said Monday the offering is subject to market conditions and other factors. Last year, the war in Ukraine, soaring inflation and recession fears caused many companies to scrap their plans to go public. Among those companies was Panera Bread, which was founded by Cava chairman and investor Ron Shaich.

Investors have had mixed reactions to fast-casual restaurant chains over the last year. Chipotle’s stock has risen 13% as price hikes have fueled sales growth, but salad chain Sweetgreen has seen its shares lose more than half their value over concerns about its path to profitability.

Cava CEO Brett Schulman told CNBC in 2019 that the company was profitable at that time, which could make the offering more attractive to potential shareholders.



Source

FDA chief warns U.S. is losing ground to China in early drug development, calls for faster trial approvals
Business

FDA chief warns U.S. is losing ground to China in early drug development, calls for faster trial approvals

Food and Drug Administration Commissioner Marty Makary warned that the U.S. is falling behind China in early-stage drug development and called for reforms that could streamline the process for starting trials on new treatments.  In an interview with CNBC on Wednesday, Makary specifically pointed to three bottlenecks that he said cause the U.S. to fall […]

Read More
Seattle Seahawks begin sale process after Super Bowl win
Business

Seattle Seahawks begin sale process after Super Bowl win

Dareke Young #83 of the Seattle Seahawks celebrates with teammates during the third quarter of the NFC Championship game against the Los Angeles Rams at Lumen Field on Jan. 25, 2026 in Seattle, Washington. Jane Gershovich | Getty Images The Seattle Seahawks are officially up for sale. The NFL team, which defeated the New England […]

Read More
FDA chief Marty Makary says ‘everything should be over the counter’ unless drug is unsafe or addictive
Business

FDA chief Marty Makary says ‘everything should be over the counter’ unless drug is unsafe or addictive

Food and Drug Administration Commissioner Marty Makary told CNBC that he believes “everything should be over the counter” unless a drug is unsafe, addictive or requires monitoring – doubling down on a push that some in the pharmaceutical industry have questioned.  In an interview Wednesday in Washington, D.C., Makary said the FDA aims to make […]

Read More